2025 annual financial data
ImmuCell 2025 Operating margin
ImmuCell 2025 operating margin with verified reported values.
Direct answer
Operating margin was 5.97%.
Operating income was 1,649,305 USD and net income was -1,040,027 USD.
Operating cash flow was 2,475,292 USD.
Get free ImmuCell email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 27,644,174 USD
- Operating income
- 1,649,305 USD
- Net income
- -1,040,027 USD
- Operating cash flow
- 2,475,292 USD